药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Heptabarbital
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Lenvatinib.
Heptabarbital
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Lenvatinib.
Heptabarbital
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Lenvatinib.
Heptabarbital
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Lenvatinib.
Heptabarbital
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Lenvatinib.
Heptabarbital
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Lenvatinib.
Heptabarbital
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Lenvatinib.
Heptabarbital
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Lenvatinib.
Heptabarbital
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lenvatinib.
Heptabarbital
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Lenvatinib.
Heptabarbital
Dexverapamil
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Dexverapamil.
Heptabarbital
Penfluridol
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Penfluridol.
Heptabarbital
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Dexchlorpheniramine.
Heptabarbital
Lorcainide
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Lorcainide.
Heptabarbital
Bunaftine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Bunaftine.
Heptabarbital
Nizofenone
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Nizofenone.
Heptabarbital
Otilonium
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Otilonium.
Heptabarbital
Sultopride
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Sultopride.
Heptabarbital
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Sitafloxacin.
Heptabarbital
Oxatomide
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Oxatomide.